Ongoing Research Report
In the News
Feb 2017: Immucor, Inc. announced that it has launched MIA FORA® NGS FLEX HLA Typing Assay, a next generation high resolution sequencing solution that provides comprehensive coverage of up to 11 HLA genes.
July 2017: Thermo Fisher Scientific Inc. announced that it has acquired Linkage Biosciences with an aim to expand its product portfolio and strengthening its presence in the HLA market.
Introduction to HLA Typing for Transplant
Human leukocyte antigen (HLA) typing is a type of genetic test used to identify certain individual variations in a person’s immune system and to match patients and donors for bone marrow or cord blood transplants. Human leukocyte antigens are proteins inherited from the parents and helps in the growth and development of new healthy blood cells and also eliminate the risk of post-transplant complications. The immune system uses HLA markers in order to locate and recognize the cell and harmful pathogens. The process of HLA typing is critical for the identification of people that can safely donate bone marrow, cord blood, or an organ to a person who needs a transplant.
Market Size and Forecast
Global HLA typing for the transplant market is projected to witness a significant growth owing to rising transplant failures which led an upsurge to match the organ transplant feasibility before the surgery to avoid any kind of loss. Factors such as a rise in the number of transplantation procedures and the number of older adult organ donors are anticipated to support the development of the global market. According to the World Health Organization, around 100,800 solid organ transplants are performed every year worldwide, out of which 69 400 are kidney transplants (46% from living donors), 20 200 are liver transplants (14.6% from living donors), 5400 are heart transplants, 3400 are lung transplants and 2400 are pancreas transplants. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purposes is estimated to drive the global market over the forecast period.
Growth Drivers
Escalating Number of Transplantation Procedures to Enhance the Global Market
HLA typing for the transplant market is projected to observe notable growth owing to the rising numbers of transplantation procedures and an increase in the number of older adult organ donors. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purpose is estimated to drive the global market over the forecast period. Furthermore, a notable gap between demand and supply of organ donations resulting in escalated patient waiting time coupled with increasing awareness levels due to government and non-government organizations is estimated to fuel the market over the forecast period.
By Region
Based on geographically, the global HLA typing for the transplant market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.
North America is projected to hold the largest share of the global market over the forecast period on account of the presence of a highly developed healthcare system, the large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.
The global HLA typing for the transplant market is further classified on the basis of region as follows:
In the News
Feb 2017: Immucor, Inc. announced that it has launched MIA FORA® NGS FLEX HLA Typing Assay, a next generation high resolution sequencing solution that provides comprehensive coverage of up to 11 HLA genes.
July 2017: Thermo Fisher Scientific Inc. announced that it has acquired Linkage Biosciences with an aim to expand its product portfolio and strengthening its presence in the HLA market.
Introduction to HLA Typing for Transplant
Human leukocyte antigen (HLA) typing is a type of genetic test used to identify certain individual variations in a person’s immune system and to match patients and donors for bone marrow or cord blood transplants. Human leukocyte antigens are proteins inherited from the parents and helps in the growth and development of new healthy blood cells and also eliminate the risk of post-transplant complications. The immune system uses HLA markers in order to locate and recognize the cell and harmful pathogens. The process of HLA typing is critical for the identification of people that can safely donate bone marrow, cord blood, or an organ to a person who needs a transplant.
Market Size and Forecast
Global HLA typing for the transplant market is projected to witness a significant growth owing to rising transplant failures which led an upsurge to match the organ transplant feasibility before the surgery to avoid any kind of loss. Factors such as a rise in the number of transplantation procedures and the number of older adult organ donors are anticipated to support the development of the global market. According to the World Health Organization, around 100,800 solid organ transplants are performed every year worldwide, out of which 69 400 are kidney transplants (46% from living donors), 20 200 are liver transplants (14.6% from living donors), 5400 are heart transplants, 3400 are lung transplants and 2400 are pancreas transplants. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purposes is estimated to drive the global market over the forecast period.
Growth Drivers
Escalating Number of Transplantation Procedures to Enhance the Global Market
HLA typing for the transplant market is projected to observe notable growth owing to the rising numbers of transplantation procedures and an increase in the number of older adult organ donors. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purpose is estimated to drive the global market over the forecast period. Furthermore, a notable gap between demand and supply of organ donations resulting in escalated patient waiting time coupled with increasing awareness levels due to government and non-government organizations is estimated to fuel the market over the forecast period.
By Region
Based on geographically, the global HLA typing for the transplant market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.
North America is projected to hold the largest share of the global market over the forecast period on account of the presence of a highly developed healthcare system, the large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.
The global HLA typing for the transplant market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
- The Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of the Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Companies Mentioned
- Immucor, Inc.
- Illumina, Inc.
- CareDx, Inc.
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- Biofortuna Limited
- Takara Bio Inc.
- Omixon Inc.
- Thermofisher Scientific
Please note the number of players as well as the addition/deletion can be done in the final deliverable as per the feasibility
